This approval allows Bionpharma to commercialize the product in the United States, expanding patient access to a more ...
With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...
LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
TRS offers a robust solution for analyzing heterogeneous samples, providing comprehensive spectral data essential for ...
Eltrombopag tablets are indicated for the treatment of thrombocytopenia (low platelet count) in specific blood disorders.
The "Canine Oral Chewable Tablets Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The canine oral chewable tablets market is evolving as pet owner ...
What motivated the shift into the veterinary space? Topelius: Actually, we started with veterinary applications. When we founded the company, our first application areas w ...
Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...
Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new ...
Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...
Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife: Our Bureau, Bengaluru Tuesday, January 13, 2026, 16:15 Hrs [IST] Bionpharma Inc. has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback